Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

EPA:CARM - Euronext Paris - Matif - FR0010828137 - REIT - Currency: EUR

17.9  +0.04 (+0.22%)

Fundamental Rating

6

CARM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. While CARM has a great profitability rating, there are some minor concerns on its financial health. CARM may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make CARM a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CARM was profitable.
In the past year CARM had a positive cash flow from operations.
CARM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CARM had a positive operating cash flow.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of CARM (4.65%) is better than 80.95% of its industry peers.
With an excellent Return On Equity value of 9.19%, CARM belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.52%, CARM belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CARM is in line with the industry average of 3.66%.
The last Return On Invested Capital (4.52%) for CARM is above the 3 year average (3.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROIC 4.52%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

CARM has a Profit Margin of 61.91%. This is in the better half of the industry: CARM outperforms 73.81% of its industry peers.
CARM's Profit Margin has improved in the last couple of years.
CARM has a better Operating Margin (89.71%) than 88.10% of its industry peers.
CARM's Operating Margin has improved in the last couple of years.
CARM has a Gross Margin (73.12%) which is comparable to the rest of the industry.
CARM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CARM is destroying value.
The number of shares outstanding for CARM has been reduced compared to 1 year ago.
Compared to 5 years ago, CARM has more shares outstanding
CARM has a better debt/assets ratio than last year.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CARM has an Altman-Z score of 0.99. This is a bad value and indicates that CARM is not financially healthy and even has some risk of bankruptcy.
CARM has a Altman-Z score (0.99) which is in line with its industry peers.
The Debt to FCF ratio of CARM is 9.40, which is on the high side as it means it would take CARM, 9.40 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CARM (9.40) is better than 80.95% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that CARM is somewhat dependend on debt financing.
CARM has a Debt to Equity ratio (0.78) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Altman-Z 0.99
ROIC/WACC0.88
WACC5.13%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.22 indicates that CARM should not have too much problems paying its short term obligations.
CARM's Current ratio of 1.22 is amongst the best of the industry. CARM outperforms 80.95% of its industry peers.
A Quick Ratio of 1.22 indicates that CARM should not have too much problems paying its short term obligations.
The Quick ratio of CARM (1.22) is better than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CARM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15358.74%, which is quite impressive.
CARM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.86% yearly.
Looking at the last year, CARM shows a quite strong growth in Revenue. The Revenue has grown by 9.72% in the last year.
CARM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.93% yearly.
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%

3.2 Future

CARM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.66% yearly.
CARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y6.95%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
EPS Next 5YN/A
Revenue Next Year7.01%
Revenue Next 2Y4.75%
Revenue Next 3Y4.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.10, the valuation of CARM can be described as very reasonable.
Based on the Price/Earnings ratio, CARM is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CARM to the average of the S&P500 Index (25.82), we can say CARM is valued rather cheaply.
CARM is valuated reasonably with a Price/Forward Earnings ratio of 9.93.
Based on the Price/Forward Earnings ratio, CARM is valued a bit cheaper than 69.05% of the companies in the same industry.
CARM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 8.1
Fwd PE 9.93
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CARM indicates a rather cheap valuation: CARM is cheaper than 90.48% of the companies listed in the same industry.
78.57% of the companies in the same industry are more expensive than CARM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.64
EV/EBITDA 11.19
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CARM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CARM may justify a higher PE ratio.
PEG (NY)1.17
PEG (5Y)0.35
EPS Next 2Y5.63%
EPS Next 3Y4.66%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.00%, CARM is a good candidate for dividend investing.
CARM's Dividend Yield is a higher than the industry average which is at 6.82.
CARM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 7%

5.2 History

The dividend of CARM decreases each year by -4.29%.
Dividend Growth(5Y)-4.29%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

54.49% of the earnings are spent on dividend by CARM. This is a bit on the high side, but may be sustainable.
DP54.49%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (5/23/2025, 7:00:00 PM)

17.9

+0.04 (+0.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-17 2025-04-17
Earnings (Next)07-23 2025-07-23
Inst Owners31.45%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap2.53B
Analysts81.33
Price Target20.65 (15.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7%
Yearly Dividend1.21
Dividend Growth(5Y)-4.29%
DP54.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.55%
PT rev (3m)3.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.25%
Revenue NY rev (3m)-2.58%
Valuation
Industry RankSector Rank
PE 8.1
Fwd PE 9.93
P/S 5
P/FCF 8.64
P/OCF 8.55
P/B 0.74
P/tB 0.74
EV/EBITDA 11.19
EPS(TTM)2.21
EY12.35%
EPS(NY)1.8
Fwd EY10.07%
FCF(TTM)2.07
FCFY11.57%
OCF(TTM)2.09
OCFY11.69%
SpS3.58
BVpS24.11
TBVpS24.1
PEG (NY)1.17
PEG (5Y)0.35
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROCE 7.04%
ROIC 4.52%
ROICexc 4.63%
ROICexgc 4.63%
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
FCFM 57.84%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
ROICexc(3y)3.79%
ROICexc(5y)3.29%
ROICexgc(3y)3.79%
ROICexgc(5y)3.29%
ROCE(3y)5.48%
ROCE(5y)4.8%
ROICexcg growth 3Y20.72%
ROICexcg growth 5Y9%
ROICexc growth 3Y20.74%
ROICexc growth 5Y9.01%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Debt/EBITDA 5.84
Cap/Depr 77.82%
Cap/Sales 0.6%
Interest Coverage 3.75
Cash Conversion 64.59%
Profit Quality 93.43%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 0.99
F-Score5
WACC5.13%
ROIC/WACC0.88
Cap/Depr(3y)129.75%
Cap/Depr(5y)102.72%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.14%
Profit Quality(3y)3321.64%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
EPS Next Y6.95%
EPS Next 2Y5.63%
EPS Next 3Y4.66%
EPS Next 5YN/A
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%
Revenue Next Year7.01%
Revenue Next 2Y4.75%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y57.69%
EBIT growth 3Y24.48%
EBIT growth 5Y10.33%
EBIT Next Year6.66%
EBIT Next 3Y4.28%
EBIT Next 5Y4.34%
FCF growth 1Y8.47%
FCF growth 3Y4.44%
FCF growth 5Y0.82%
OCF growth 1Y7.33%
OCF growth 3Y4.74%
OCF growth 5Y1.02%